Life Science Investing Forte Biosciences, Inc. Announces Third Quarter 2025 Results and Provides Update
Life Science Investing Forte Biosciences, Inc. Announces Presentation of FB102 Celiac Disease Trial at Tampere Celiac Disease Symposium
Nine Mile Metals Announces Certified High-Grade Assay Results up to 15.00% Copper from the Wedge Project, Bathurst, New Brunswick
Apollo Silver Announces $2.5 Million Upsize to Previously Announced Financing to Allow for Insider Participation
CORRECTION: Nextech3D.ai Provides Shareholder Update on Krafty Labs Acquisition and Announces $321,917 CEO Investment
